Bill > HB1452

This bill requires health insurance plans in North Dakota to include coverage for at least two FDA-approved antiobesity medications for chronic weight management, with coverage criteria that cannot be more restrictive than the FDA's approved indications. Insurance providers can apply standard cost-sharing requirements like deductibles, copayments, and coinsurance, consistent with other pharmaceutical coverage. Insurers must provide written notice to policyholders about this coverage, prominently positioned in their literature and communications. The Public Employees Retirement System is mandated to prepare a report for the 70th legislative assembly detailing the impact of these prescription drug benefits, including utilization rates, costs, and recommendations for continued coverage. The bill will apply to health benefits coverage starting after June 30, 2025, and will remain in effect until June 30, 2027, after which the requirements will expire unless renewed. The legislation aims to improve access to medications for patients managing obesity by ensuring insurance coverage and transparency.

Government Affairs

https://ndlegis.gov/assembly/69-2025/regular/bill-overview/bo1452.html